Edition:
India

Neovasc Inc (NVCN.OQ)

NVCN.OQ on NASDAQ Stock Exchange Capital Market

0.05USD
1:30am IST
Change (% chg)

$0.00 (+1.88%)
Prev Close
$0.05
Open
$0.05
Day's High
$0.05
Day's Low
$0.05
Volume
5,548,421
Avg. Vol
6,397,625
52-wk High
$1.88
52-wk Low
$0.03

Select another date:

Thu, Feb 1 2018

BRIEF-Neovasc Receives German Nub Status 1 Designation For Neovasc Reducer Procedure

* NEOVASC ANNOUNCES RECEIPT OF GERMAN NUB STATUS 1 DESIGNATION FOR NEOVASC REDUCER™ PROCEDURE FOR TREATMENT OF REFRACTORY ANGINA Source text for Eikon: Further company coverage:

BRIEF-Fred Colen Appointed CEO Of Neovasc Inc

* FRED COLEN APPOINTED CHIEF EXECUTIVE OFFICER OF NEOVASC INC.

BRIEF-Capital World Investors Reports A 13.8 Percent Passive Stake In Neovasc Inc

* CAPITAL WORLD INVESTORS REPORTS A 13.8 PERCENT PASSIVE STAKE IN NEOVASC INC AS OF NOVEMBER 30, 2017 - SEC FILING Source text : [http://bit.ly/2kZxgLY] Further company coverage:

BRIEF-Neovasc announces qtrly loss per share $0.06

* Neovasc Inc - ‍Revenues decreased 55% to $1.4 million for three months ended September 30, 2017, compared to revenues of $3.0 million ​

BRIEF-Neovasc announces 65 million dollars offering of common shares and warrants

* NEOVASC ANNOUNCES US$65 MILLION UNDERWRITTEN OFFERING OF UNITS CONSISTING OF COMMON SHARES AND WARRANTS TO PURCHASE COMMON SHARES AND CONCURRENT PRIVATE PLACEMENT OF NOTES AND WARRANTS

BRIEF-Neovasc receives FDA approval to initiate pivotal reducer trial

* Neovasc receives FDA approval to initiate pivotal reducer trial

BRIEF-Neovasc provides litigation update

* Says Court Of Appeals affirmed judgment of U.S. District Court for District of Massachusetts in case of Cardiaq Valve Tech versus co

Select another date: